Director/PDMR Shareholding
Summary by AI BETAClose X
Craneware plc
(“Craneware” or the “Company”)
Director/ PDMR Shareholding
Vesting of Long Term Incentive Plan Awards and Total Voting Rights
24 September 2026 – The Board of Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 22 September 2026, under the terms of the Craneware plc Long Term Incentive Plan (2022) (“LTIP”), conditional awards of ordinary shares of 1p each in the Company (“Shares”) which were granted to three Directors of the Company and to the Company’s Chief Legal Officer, who is also a person discharging managerial responsibility (‘PDMR’), vested to the extent that certain performance conditions were satisfied.
As noted below, Keith Neilson, CEO of the Company, received 34,113 ordinary shares of 1p each in the Company (“Shares”). Mr. Neilson has chosen to retain the full quantity of Shares from the vesting of this conditional award rather than utilising the Company’s net settlement facility to settle the income tax and national insurance contributions. These represent a total cost to Mr. Neilson of over £196,000 to retain the full award.
Following the vesting of this conditional award and payment of the associated tax liabilities, Mr. Neilson’s shareholding in the Company has increased to 3,257,658 Ordinary Shares in the capital of the Company, representing 9.48% of the Company’s issued share capital (excluding 1,162,996 Ordinary Shares held in treasury).
|
Director / other PDMR |
Gross number of Shares from conditional share awards vested on 22 September 2026 |
Number of shares withheld to satisfy tax liabilities on vesting of conditional share awards |
Net number of Shares received from conditional share awards vested on 22 September 2026 |
Percentage of issued share capital* of the Company |
|
|
|
|
|
|
|
Keith Neilson (CEO) |
34,113 |
- |
34,113 |
0.099% |
|
|
|
|
|
|
|
Craig Preston (CFO) |
25,356 |
(14,656) |
10,700 |
0.031% |
|
|
|
|
|
|
|
Isabel Urquhart (CPO) |
17,429 |
(10,074) |
7,355 |
0.021% |
|
|
|
|
|
|
|
Eric Carter (CLO) |
14,110 |
(3,514) |
10,596 |
0.031% |
|
|
|
|
|
|
*excluding 1,162,996 Ordinary Shares held in treasury.
The net amount of Shares received by the CFO, CPO and the Chief Legal Officer, as shown in the table above, from the vested LTIP awards was after payment of the associated tax liabilities. No consideration was payable by each of these two Directors or by the other PDMR to receive the Shares from these LTIP awards.
The net number of Shares from these vested LTIP awards received by each of the three Directors and the other PDMR are subject to a two year post-vesting holding period.
Following this transaction, Craig Preston holds 111,542 Shares which is 0.324% of the issued share capital* of the Company, Isabel Urquhart holds 25,466 Shares which is 0.074% of the issued share capital* of the Company and Eric Carter holds 39,016 Shares which is 0.113% of the issued share capital* of the Company.
Total Voting Rights
Following the vesting of these conditional share awards and also the vesting of conditional share awards for certain other employees on 22 September 2026, the Company is transferring or has transferred a total of 142,025 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company’s issued share capital now consists of 35,542,169 Ordinary Shares, of which 1,162,996 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 34,379,173. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
PDMR Notification: Keith Neilson
- Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
- Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary Shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Vesting of conditional share award under the Craneware plc Long Term Incentive Plan (2022)
d) Price(s) and volume(s) Volume(s) 34,113, Price(s) £0
e) Aggregated information:
i. Aggregated volume 34,113
ii. Price £0
f) Date of the transaction 2026-09-22
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
- Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
- Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 25,356, Price(s) £0
2) Volumes(s) surrendered 14,656, Price(s) £10.35
e) Aggregated information:
i. Aggregated volume 1) 25,356
2) 14,656
ii. Price(s) 1) £0
2) £10.35
f) Date of the transaction 2026-09-22
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
- Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
- Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 17,429, Price(s) £0
2) Volumes(s) surrendered 10,074, Price(s) £10.35
e) Aggregated information:
i. Aggregated volume 1) 17,429
2) 10,074
ii. Price(s) 1) £0
2) £10.35
f) Date of the transaction 2026-09-22
g) Place of the transaction Outside a trading venue
PDMR notification: Eric Carter
- Details of the Restricted Person / person closely associated with him or her
a) Name Eric Carter
- Reason for the notification
a) Position / status Chief Legal Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 14,110, Price(s) £0
2) Volumes(s) surrendered 3,514, Price(s) £10.35
e) Aggregated information:
i. Aggregated volume 1) 14,110
2) 3,514
ii. Price(s) 1) £0
2) £10.35
f) Date of the transaction 2026-09-22
g) Place of the transaction Outside a trading venue
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Louisa El-Ahwal craneware@almastrategic.com
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Virginia Bull, Arnav Kapoor
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Oxford Nanopore Technologies
- 10 hours ago AVI Global Trust
- 10 hours ago LSL Property Services
- 10 hours ago Bluebird Merchant Ventures (DI)
- 11 hours ago Power Probe PLC